Company
Overview
Leadership
Social Accountability
Technology
RJX Technology
Therapeutic Areas
Pipeline
Clinical Trials
Contact
Contact Us
Join Reven
News
Latest News
Research
Investor Portal
2017/07/03 Reven News Press
July 3, 2017
| Featured
Canadian Intellectual Property Office approved our Family Two patent in Canada.
More Reven News Releases
|
More Research & Development